Kelly Jared, CEO of Oncolytics Biotech Inc. ($ONCY), bought shares on the open market three times in the past year, totaling about $34,000. His most recent purchase was on March 12, 2026. These buys rank 3,335th among nearly 5,000 insiders, below the average of $1.46 million per buyer and 3.3 transactions. Jared made no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Kelly Jared | Chief Executive Officer | P | Common Shares | 5050 | $0.96 | 114,050.0000 | 80,020,131 | 4.63% | 0.01% |
| Feb. 11, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Kelly Jared | Chief Executive Officer | P | Common Shares | 5600 | $0.84 | 79,500.0000 | 80,020,131 | 7.58% | 0.01% |
| Feb. 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Kelly Jared | Chief Executive Officer | P | Common Shares | 29500 | $0.84 | 109,000.0000 | 80,020,131 | 37.11% | 0.04% |